CNTB

Connect Biopharma Holdings

CNTB

Market cap $150M

2.69 USD

-0.04

1.47%

At close Updated Dec 26, 4:00 PM EST

Pre-market

After hours

2.69

0.00

1 day

-1.47%

5 days

17.98%

1 month

-4.95%

3 months

70.25%

6 months

177.18%

Year to date

122.31%

1 year

177.32%

5 years

-85.45%

10 years

-85.45%

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62

Healthcare Biotechnology